Skip Ribbon Commands
Skip to main content
News
 
 
  • PHOENIX group on steady course
    The PHOENIX group brings the fiscal year 2011/2012 to a successful close.
  • PHOENIX obtains temporary injunction against suspension of deliveries by Novartis
    PHOENIX has successfully prevailed against the delivery suspension by Novartis in Germany with a temporary injunction.
  • Delivery suspension by Novartis puts supply to German pharmacies at risk
    PHOENIX, the market leader in pharmaceutical wholesale in Germany supplying 10,000 pharmacies with pharmaceutical products, has stopped receiving deliveries in Germany from Novartis since mid-November.
  • PHOENIX group rewards excellence in fundamental pharmaceutical research
    The PHOENIX group, leading pharmaceutical wholesaler in Europe, awarded the PHOENIX Pharmaceutics Science Award 2011.
  • Personnel update: Iberl retires, Windholz takes over
    Henry Iberl, long-standing member of the Executive Board of PHOENIX group, Mannheim, Germany, has retired yesterday as planned after 33 years of service within the company.
 
 
 
 
 
Group Communications
PHOENIX group
Pfingstweidstraße 10-12
D-68199 Mannheim
e-mail